
    
      PRIMARY OBJECTIVES:

        1. To compare the cellular and humoral vaccine response post-transplant between the two
           arms by performing Elisa, and T-cell enzyme-linked immunospot (ELISPOT) assays

        2. To determine the feasibility and safety of this approach

      SECONDARY OBJECTIVES:

        1. To compare post-transplant recovery of innate and adaptive immune cells (CD8, CD4, CD19,
           NK, γδ T-cells), in addition to T-cell phenotype markers between the two arms.

        2. To compare post-transplant recovery of T-regs and MDSCs between the two arms.

        3. To compare progression free survival (PFS) at 2 years post-transplant
    
  